Reuters: Health
AstraZeneca Plc said on Tuesday it would sell the global commercial rights for its drug to treat acid reflux to German pharmaceutical company Cheplapharm Arzneimittel GmbH for as much as $276 million.
AstraZeneca sells acid reflux drug rights to Germany's Cheplapharm
AstraZeneca sells acid reflux drug rights to Germany's Cheplapharm
Reuters: Health
AstraZeneca Plc said on Tuesday it would sell the global commercial rights for its drug to treat acid reflux to German pharmaceutical company Cheplapharm Arzneimittel GmbH for as much as $276 million.
Reuters: Health
AstraZeneca Plc said on Tuesday it would sell the global commercial rights for its drug to treat acid reflux to German pharmaceutical company Cheplapharm Arzneimittel GmbH for as much as $276 million.
Subscribe to:
Post Comments (Atom)
Popular Posts
|
No comments:
Post a Comment